These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1856211)

  • 1. Thrombin Glu-39 restricts the P'3 specificity to nonacidic residues.
    Le Bonniec BF; MacGillivray RT; Esmon CT
    J Biol Chem; 1991 Jul; 266(21):13796-803. PubMed ID: 1856211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glu-192----Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin.
    Le Bonniec BF; Esmon CT
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7371-5. PubMed ID: 1678522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation.
    Schneider M; Nagashima M; Knappe S; Zhao L; Morser J; Nesheim M
    J Biol Chem; 2002 Mar; 277(12):9944-51. PubMed ID: 11786552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of thrombin's Tyr-Pro-Pro-Trp motif in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors.
    Le Bonniec BF; Guinto ER; MacGillivray RT; Stone SR; Esmon CT
    J Biol Chem; 1993 Sep; 268(25):19055-61. PubMed ID: 8395526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence specificities of human fibroblast and neutrophil collagenases.
    Netzel-Arnett S; Fields GB; Birkedal-Hansen H; Van Wart HE
    J Biol Chem; 1991 Apr; 266(11):6747-55. PubMed ID: 1849891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel recombinant serpin with potential antithrombotic properties.
    Hopkins PC; Crowther DC; Carrell RW; Stone SR
    J Biol Chem; 1995 May; 270(20):11866-71. PubMed ID: 7744836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
    Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
    Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the thrombin insertion loop 144-155. Study of thrombin mutations W148G, K154E and a thrombin-based synthetic peptide.
    Bouton MC; Plantier JL; Dembak M; Guillin MC; Rabiet MJ; Jandrot-Perrus M
    Eur J Biochem; 1995 Apr; 229(2):526-32. PubMed ID: 7744076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary substrate binding in aspartic proteinases: contributions of subsites S3 and S'2 to kcat.
    Balbaa M; Cunningham A; Hofmann T
    Arch Biochem Biophys; 1993 Nov; 306(2):297-303. PubMed ID: 8215428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing.
    Chagas JR; Hirata IY; Juliano MA; Xiong W; Wang C; Chao J; Juliano L; Prado ES
    Biochemistry; 1992 Jun; 31(21):4969-74. PubMed ID: 1599922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors.
    Hofsteenge J; Taguchi H; Stone SR
    Biochem J; 1986 Jul; 237(1):243-51. PubMed ID: 3026312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of serpin specificity: cooperative interactions in the reactive-site loop sequence of antithrombin specifically restrict the inhibition of activated protein C.
    Hopkins PC; Pike RN; Stone SR
    J Mol Evol; 2000 Nov; 51(5):507-15. PubMed ID: 11080374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation of human alpha-thrombin by the myeloperoxidase-H2O2-chloride system: structural and functional effects.
    De Cristofaro R; Landolfi R
    Thromb Haemost; 2000 Feb; 83(2):253-61. PubMed ID: 10739383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity mapping of HIV-1 protease by reduced bond inhibitors.
    Majer P; Urban J; Gregorová E; Konvalinka J; Novek P; Stehlíková J; Andreánsky M; Sedlácek J; Strop P
    Arch Biochem Biophys; 1993 Jul; 304(1):1-8. PubMed ID: 8323274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of an extracellular proteinase from Brevibacterium linens ATCC 9174 on bovine alpha s1-casein.
    Rattray FP; Fox PF; Healy A
    Appl Environ Microbiol; 1996 Feb; 62(2):501-6. PubMed ID: 8593051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of glutamic acid 192 to glutamine in activated protein C changes the substrate specificity and increases reactivity toward macromolecular inhibitors.
    Rezaie AR; Esmon CT
    J Biol Chem; 1993 Sep; 268(27):19943-8. PubMed ID: 8104182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of an extracellular proteinase from Brevibacterium linens ATCC 9174 on bovine beta-casein.
    Rattray FP; Fox PF; Healy A
    Appl Environ Microbiol; 1997 Jun; 63(6):2468-71. PubMed ID: 9172371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
    Rezaie AR
    Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1.
    Rezaie AR
    Biochemistry; 1998 Sep; 37(38):13138-42. PubMed ID: 9748320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of the unusual cleavage specificity of lysyl-bradykinin-releasing kallikreins.
    Chagas JR; Portaro FC; Hirata IY; Almeida PC; Juliano MA; Juliano L; Prado ES
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):63-9. PubMed ID: 7864830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.